希森美康签约Fujirebio,拿下AD血检产品代理!

IVD从业者网
Feb 07

纽约当地时间2月5日,希森美康宣布已与Fujirebio富士瑞必欧就痴呆检测达成销售合作协议。根据协议,希森美康将在特定区域独家销售富士瑞必欧的Lumipulse免疫检测系统及痴呆相关检测产品。此次合作基于两家日本公司于2023年在免疫检测技术领域建立的协作关系。合作协议下的销售将从巴西开始,随后扩展至整个中南美洲,并进入中东、亚洲及其他地区。协议的财务及其他条款未予披露。Fujirebio富士...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10